Literature DB >> 7066734

Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymectomy compared to other surgical procedures.

R P Grant, L C Jenkins.   

Abstract

In a recent report Leventhal, Orkin, and Hirsh described a scoring system felt to be of value in predicting the need for postoperative mechanical ventilation in patients with myasthenia gravis undergoing thymectomy. Leventhal, et al. identified four risk factors felt to have predictive value, namely: (1) duration of myasthenia gravis greater than or equal to 6 years, (2) chronic respiratory disease, (3) dose of pyridostigmine greater than or equal to 750 mg per day, and (4) vital capacity less than or equal to 2.9 litres. Forty-six patients with myasthenia gravis who received 68 general anaesthetics were studied retrospectively. They represented the past 10 years' anaesthetic experience with myasthenia gravis at the Vancouver General Hospital. The patients were divided into two groups: (1) those who underwent thymectomy, and (2) those who underwent procedures other than thymectomy. Using the risk factors of Leventhal, et al., a predictive score was assessed for each patient; the time of postoperative tracheal extubation was also noted for each patient. From this study it was concluded that the scoring system proposed by Leventhal, et al. may have been of some value in predicting whether or not a particular patient undergoing thymectomy was likely to need ventilation postoperatively. In 41 myasthenics who had procedures other than thymectomy, however, this scoring system was found to be of no value.

Entities:  

Mesh:

Year:  1982        PMID: 7066734     DOI: 10.1007/bf03007987

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  13 in total

Review 1.  Myasthenia gravis (first of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-19       Impact factor: 91.245

2.  Anesthesia for transcervical thymectomy in myasthenia gravis.

Authors:  D S Girnar; A I Weinreich
Journal:  Anesth Analg       Date:  1976 Jan-Feb       Impact factor: 5.108

3.  Long-term effects of repeated plasma exchange in myasthenia gravis.

Authors:  J Newsom-Davis; S G Wilson; A Vincent; C D Ward
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

4.  Prolongation of suxamethonium following plasma exchange.

Authors:  J Lumley
Journal:  Br J Anaesth       Date:  1980-11       Impact factor: 9.166

5.  Progressive depletion of plasma cholinesterase during daily plasma exchange.

Authors:  J L Paterson; E S Walsh; G M Hall
Journal:  Br Med J       Date:  1979-09-08

Review 6.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

Review 7.  Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.

Authors:  J A Simpson
Journal:  Muscle Nerve       Date:  1978 Mar-Apr       Impact factor: 3.217

Review 8.  Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.

Authors:  J A Simpson
Journal:  Muscle Nerve       Date:  1978 Jan-Feb       Impact factor: 3.217

9.  Prediction of the need for postoperative mechanical ventilation in myasthenia gravis.

Authors:  S R Leventhal; F K Orkin; R A Hirsh
Journal:  Anesthesiology       Date:  1980-07       Impact factor: 7.892

10.  Anesthetic considerations for myasthenia gravis and pregnancy.

Authors:  W H Rolbin; G Levinson; S M Shnider; R G Wright
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

View more
  2 in total

1.  Multivariate determinants of the need for postoperative ventilation in myasthenia gravis.

Authors:  M Naguib; A A el Dawlatly; M Ashour; E A Bamgboye
Journal:  Can J Anaesth       Date:  1996-10       Impact factor: 5.063

2.  Laparoscopic Sleeve Gastrectomy in a Morbidly Obese Patient with Myasthenia Gravis: A Review of the Management.

Authors:  Megana Ballal; Tracey Straker
Journal:  Case Rep Med       Date:  2015-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.